French Logistics Stock News

ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Dupixent’s AFRS Approval Adds Depth To Sanofi’s Specialty Care Story

Sanofi’s Dupixent has received US FDA approval for treating allergic fungal rhinosinusitis, the first targeted biologic cleared for this condition. The approval covers both adult and pediatric patients, offering a new option where standard therapies often fall short. This decision expands Dupixent’s label within respiratory and immunology care and reinforces Sanofi’s focus on specialty medicines. For investors watching ENXTPA:SAN, this approval arrives at a time when the share price is...
ENXTPA:SCR
ENXTPA:SCRInsurance

SCOR (ENXTPA:SCR) Net Margin Rebound Tests Underwriting Improvement Narrative

SCOR (ENXTPA:SCR) has just wrapped up FY 2025 with fourth quarter revenue of €3.1b and basic EPS of €1.18, alongside net income of €209m that caps a trailing twelve month EPS of €4.80 on revenue of €12.4b and net income of €851m. The company has seen quarterly revenue range between €3.0b and €4.8b through 2025, with basic EPS moving between €1.12 and €1.26 across the first three quarters before landing at €1.18 in Q4. These figures are set against a prior year that included both positive and...
ENXTPA:BNP
ENXTPA:BNPBanks

BNP Paribas Joins Euro Stablecoin Push With Potential New Fee Streams

BNP Paribas (ENXTPA:BNP) is part of a banking consortium preparing to launch a regulated euro stablecoin. The consortium is seeking Electronic Money Institution approval in the Netherlands. The launch is targeted for the second half of 2026, subject to regulatory clearance. The euro stablecoin is intended for compliant digital payments and settlement within the EU. BNP Paribas is a large European banking group with activities across retail banking, corporate lending, markets and securities...
ENXTPA:FGR
ENXTPA:FGRConstruction

A Look At Eiffage (ENXTPA:FGR) Valuation After Full-Year Earnings And Higher Dividend Announcement

Eiffage (ENXTPA:FGR) has just reported its full year 2025 earnings, with sales of €26,119 million and net income of €1,022 million, and paired this with an annual dividend of €4.80 per share. See our latest analysis for Eiffage. Eiffage’s share price has climbed to €140.35, with a 30 day share price return of 11.39% and 90 day share price return of 17.99%. The 1 year total shareholder return of 40.86% signals stronger momentum over a longer horizon. If this earnings release has you thinking...
ENXTPA:ML
ENXTPA:MLAuto Components

Is It Time To Reassess Michelin (ENXTPA:ML) After Recent Share Price Swings?

If you are wondering whether Compagnie Générale des Établissements Michelin Société en commandite par actions is attractively priced right now, you are not alone. The current share price of €31.92 naturally raises questions about what you are really paying for. The stock has been through mixed recent moves, with a 6.9% decline over the last week, a 1.5% return over the last 30 days, an 11.4% gain year to date and a 1.4% decline over the last year. The 3 year and 5 year returns sit at 21.1%...
ENXTPA:DSY
ENXTPA:DSYSoftware

Is Dassault Systèmes (ENXTPA:DSY) Now Attractive After A 53% One Year Share Price Slide

If you are wondering whether Dassault Systèmes is starting to look attractively priced or still expensive, this article will walk through what the numbers are saying about its current valuation. The shares last closed at €18.18, with recent returns of 0.8% over 7 days, a 21.6% decline over 30 days, a 22.3% decline year to date, and a 53.3% decline over 1 year. This naturally raises questions about how the market is now weighing growth potential against risk. These moves sit against a...
ENXTPA:LI
ENXTPA:LIRetail REITs

Should Governance Changes and a Higher Dividend Require Action From Klépierre (ENXTPA:LI) Investors?

Klépierre recently reported governance changes, including the resignation of long-serving Supervisory Board Chairman David Simon and the planned departure of Audit Committee Chair John Carrafiell, while appointing the Vice-Chairwoman as interim Chair. At the same time, the company proposed a 3% year-on-year increase in its 2025 cash dividend to €1.90 per share, signaling a continued focus on shareholder returns amid boardroom transitions. We’ll now examine how the leadership reshuffle,...
ENXTPA:RUI
ENXTPA:RUIGas Utilities

A Look At Rubis (ENXTPA:RUI) Valuation After Its Recent Share Price Momentum

Rubis stock snapshot after recent performance Rubis (ENXTPA:RUI) has quietly outperformed many peers over the past year, with a 1 year total return of 44.67% and past 3 months and month returns of 8.15% and 2.11% respectively. Over a longer horizon, the 3 year total return of 68.98% and 5 year total return of 20.92% sit alongside annual revenue of €6.58b and net income of €376.24m, giving investors a richer picture of the group’s profile. See our latest analysis for Rubis. With the share...
ENXTPA:RNO
ENXTPA:RNOAuto

Renault Ampere Bets On Basquevolt Batteries To Reset EV Investment Case

Renault's EV and software unit Ampere has signed a joint development agreement with Basquevolt to work on next generation lithium metal based batteries. The partnership focuses on accelerating development and validation of higher energy density, safer and faster charging cells for future electric vehicles. The companies aim to prepare this technology for potential commercial use in upcoming Renault models. For Renault (ENXTPA:RNO), this move comes at a time when investors have seen a 20.2%...
ENXTPA:IPS
ENXTPA:IPSMedia

Ipsos Buyback And Leadership Shift Put Shareholder Returns In Focus

Ipsos has launched a €100 million share buyback programme as part of its capital allocation plans. The company has announced leadership changes, with Laurence Stoclet appointed President following the resignation of long standing Chairman Didier Truchot for health reasons. The share buyback and governance shift are recent developments that have not yet been widely discussed and may be relevant for holders of ENXTPA:IPS. For investors tracking ENXTPA:IPS, these updates come at a time when...
ENXTPA:AM
ENXTPA:AMAerospace & Defense

Is It Too Late To Consider Dassault Aviation (ENXTPA:AM) After Its Strong Multi‑Year Rally?

If you are wondering whether Dassault Aviation société anonyme is still priced reasonably or starting to look expensive, you are not alone. The share price recently closed at €347.00, with returns of 0.9% over 7 days, 9.5% over 30 days, 23.8% year to date, 22.8% over 1 year, 128.1% over 3 years and 293.5% over 5 years. This naturally raises questions about what is already reflected in the price. Recent news coverage around Dassault Aviation société anonyme has focused on its position in the...
ENXTPA:HO
ENXTPA:HOAerospace & Defense

Assessing Thales (ENXTPA:HO) Valuation After Recent Share Price Pullback And Undervaluation Signals

Thales share performance and recent context Thales (ENXTPA:HO) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past week and month, while remaining positive over the past 3 months and year to date. See our latest analysis for Thales. At a share price of €250.7, Thales has recently given back some ground with a 30 day share price return of a 2.45% decline. However, its 90 day share price return of 11.57% and 5 year total shareholder...
ENXTPA:FR
ENXTPA:FRAuto Components

Assessing Valeo (ENXTPA:FR) Valuation After Earnings, 2026 Guidance And Dividend Proposal

Earnings, guidance and dividend proposal put Valeo (ENXTPA:FR) in focus Valeo (ENXTPA:FR) has drawn attention after reporting full year 2025 results, issuing 2026 guidance and proposing a €0.44 per share dividend. This combined update gives investors several data points to reassess the stock. See our latest analysis for Valeo. Despite the earnings, guidance and dividend proposal, Valeo’s 1 week share price return of a 13.28% decline and 1 month share price return of a 7.08% decline contrast...
ENXTPA:ABVX
ENXTPA:ABVXBiotechs

A Look At Abivax Société Anonyme’s Valuation After New Obefazimod Data At ECCO 2026

Why obefazimod data at ECCO 2026 matters for ABIVAX Société Anonyme (ENXTPA:ABVX) ABIVAX Société Anonyme (ENXTPA:ABVX) drew fresh attention after releasing new preclinical and Phase 3 data for its lead drug obefazimod at ECCO 2026, focused on inflammatory bowel disease. The company highlighted anti fibrotic signals in Crohn’s disease models, rapid symptomatic relief in ulcerative colitis, and safety data where serious treatment emergent adverse events and discontinuations were broadly...
ENXTPA:AF
ENXTPA:AFAirlines

Air France-KLM (ENXTPA:AF) Valuation After EU Court Fine And Middle East Flight Suspensions

Air France-KLM (ENXTPA:AF) is back in focus after the EU Court of Justice rejected its appeal over historical cargo cartels, confirming €368 million in fines and coinciding with temporary suspensions on select Middle East routes. See our latest analysis for Air France-KLM. The court ruling and temporary Middle East suspensions came after a tougher period for the stock, with a 7 day share price return of 19.0% decline and a year to date share price return of 15.1% decline. This is despite the...
ENXTPA:DG
ENXTPA:DGConstruction

Vinci (ENXTPA:DG) Valuation Check After Recent Share Price Momentum And Mixed Fair Value Signals

Vinci share move puts recent returns and fundamentals in focus Vinci (ENXTPA:DG) has attracted fresh interest after its recent share move, with investors weighing the stock’s month and past 3 months performance against its earnings profile and current valuation signals. See our latest analysis for Vinci. Vinci’s recent 10.18% 1 month share price return leaves it ahead of its 10.73% year to date share price return, while the 1 year total shareholder return of 18.97% points to momentum that has...
ENXTPA:VIE
ENXTPA:VIEIntegrated Utilities

Why Veolia Environnement (ENXTPA:VIE) Is Down 5.5% After Strong 2026 Outlook And Higher Dividend

In late February 2026, Veolia Environnement reported slightly lower 2025 sales of €44,396 million but higher net income of €1,217 million, issued upbeat 2026 earnings guidance, and proposed lifting its cash dividend to €1.50 per share, alongside progress on acquiring Clean Earth. At the same time, Veolia highlighted very large new municipal and hazardous waste contracts in India and over £1 billion of fresh UK local authority wins, underscoring how long-term, regulation-driven water, waste,...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Assessing Airbus (ENXTPA:AIR) Valuation After Record Air Astana A320neo Order

Why Air Astana’s record Airbus order matters for Airbus shareholders Airbus (ENXTPA:AIR) just secured its largest direct order from Air Astana Group, a 25 jet A320neo Family deal that supports the airline’s fleet renewal, route growth and sustainability plans. See our latest analysis for Airbus. Against the backdrop of this new Air Astana order and other recent customer activity such as British Airways’ A380 cabin upgrade plans and expanded SAF supply agreements, Airbus shares now trade at...
ENXTPA:MF
ENXTPA:MFDiversified Financial

A Look At Wendel (ENXTPA:MF) Valuation After A Loss-Making Year And Higher 2025 Dividend

What Wendel’s 2025 results and dividend move could mean for shareholders Wendel (ENXTPA:MF) reported 2025 sales of €7,782.8 million alongside a net loss of €151.8 million, and is proposing an 8.5% higher ordinary dividend of €5.10 per share for shareholder approval. For you as an investor, that mix of loss-making financials and a higher dividend raises some practical questions about how sustainable the payout is, how it fits with Wendel’s balance sheet approach, and what it could imply for...
ENXTPA:CAP
ENXTPA:CAPIT

Is Capgemini (ENXTPA:CAP) Now Interesting After Recent Share Price Weakness?

If you are wondering whether Capgemini shares are starting to look interesting after recent weakness, this article will walk through what the current price might be implying about value. The stock last closed at €107.10, with a 5.8% gain over the past 7 days set against declines of 20.3% over 30 days, 23.9% year to date, and 27.3% over 1 year, as well as a 36.3% decline over 3 years and 18.6% over 5 years. Recent news coverage around Capgemini has focused on the broader IT services sector,...
ENXTPA:VU
ENXTPA:VUElectronic

Vusion (ENXTPA:VU) Is Down 6.4% After Carrefour AI Store Deal And 2025 Results Update – Has The Bull Case Changed?

Vusion S.A. recently reported full-year 2025 results showing sales of €1,472 million and net income of €84.2 million, and announced an annual dividend of €0.90 per share to be paid on June 12, 2026. A new long-term partnership with Carrefour to digitalize all French hypermarkets and supermarkets by 2030, alongside a Qualcomm-backed AI-Native Store vision, underscores Vusion’s push to embed its platform at the core of future physical retail infrastructure. Now we’ll examine how the Carrefour...
ENXTPA:NK
ENXTPA:NKBasic Materials

Imerys (ENXTPA:NK) Q4 Loss Of €518.8m Tests Bullish Margin Recovery Narrative

Imerys (ENXTPA:NK) has reported full year 2025 results with fourth quarter revenue of €800.7 million and a basic EPS loss of €6.15, while trailing twelve month revenue came in at €3.4 billion with a basic EPS loss of €4.83. The company has seen quarterly revenue move across a fairly tight band, from €831.3 million in Q4 2024 through €885.6 million in Q2 2025, while net income has swung from a profit of €47.5 million in that second quarter to a loss of €518.8 million in Q4, putting the focus...
ENXTPA:EAPI
ENXTPA:EAPIPharmaceuticals

Euroapi (ENXTPA:EAPI) Losses On €852.6 Million TTM Revenue Test Margin Recovery Narrative

Euroapi (ENXTPA:EAPI) has posted its latest full year 2025 numbers with first half revenue of €414.5 million and a basic EPS loss of €0.30, while trailing twelve month revenue sits at €852.6 million against a net income loss of €211.2 million. Over recent periods the company has seen revenue move from €450.9 million in the first half of 2024 to €468.3 million in the second half of 2024 and then to €414.5 million in the first half of 2025. This has come alongside basic EPS losses of €0.37,...
ENXTPA:AKE
ENXTPA:AKEChemicals

Arkema (ENXTPA:AKE) Is Down 5.6% After Upholding Dividend Despite Q4 Losses Has The Bull Case Changed?

Arkema S.A. has reported past fourth-quarter 2025 sales of €2,105 million and a net loss of €68 million, alongside full-year 2025 sales of €9,068 million and net income of €63 million, while also confirming an annual dividend of €3.60 per share payable in May 2026. The sharp contrast between weaker earnings and the maintained dividend highlights management’s focus on sustaining shareholder returns despite a more pressured profit picture. We’ll now consider how the combination of lower...